Stay updated on Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page
- Check5 days agoChange DetectedA new publication citation by Poddubnyy et al. on extramusculoskeletal manifestations in Upadacitinib-treated Psoriatic Arthritis or Axial Spondyloarthritis was added to the Publications section. This expands the study's referenced literature and highlights ongoing related research.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded an NIH grant/contract funding line to the study details and updated the page revision to v3.6.6 (removing the previous v3.6.5).SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision changed from v3.6.4 to v3.6.5, indicating a new version of the page template. The update likely reflects structural or UI improvements rather than additions or deletions to study content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe revision metadata updated from v3.6.3 to v3.6.4. This appears to be a minor system/documentation update with no substantive changes to the study details.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3. This indicates a small page-build update and does not modify the study text or data.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page’s revision tag was updated from Revision: v3.6.0 to Revision: v3.6.2, signaling a new version of the page content rather than changes to the study information.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page.